Australian media billionaire Kerry Stokes led an $8.8 billion buyout approach for the country's top steelmaker BlueScope , a ...
While it's not ready to join the workforce yet, Atlas, an AI-powered humanoid, is learning how to do human tasks.
When first responders arrived at the upstate New York home of Cathy Krauseneck, they had no idea of the horror they were about to uncover. Krauseneck lay dead in her bed with an ax still stuck in her ...
The four astronauts have been living in orbit for more than two weeks. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The four astronauts of ...
As artificial intelligence (AI) becomes increasingly embedded in everyday products, the way we define and design experiences is undergoing a profound shift. We are moving from traditional user ...
The minute I open my mouth, it’s clear that I’m from New York (Brooklyn, to be exact). And though my high school speech teachers did their best to beat the accent out of me—and I do tamp it down—it’s ...
The Crew Dragon for the Ax-4 mission atop its Falcon 9 rocket on the launch pad at the Kennedy Space Center. Credit: SpaceX WASHINGTON — A propellant leak in a Falcon 9 booster has delayed the launch ...
The mission, which was recently delayed for the second time, is due to get off the ground once again from NASA's Kennedy Space Center in Cape Canaveral, Florida. The crew will be under the command of ...
Ax Sharma is a security researcher and journalist focused on malware analyses and cybercrime investigations. His expertise includes open source software security, threat intel analysis, and reverse ...
Back in the 70s, if you wanted to see a good heavyweight fight, you salivated for Ali vs. Frazier. When it comes to bow releases each fall, the most-anticipated heavyweight match is Mathews vs. Hoyt.
The 6-year-old boy found the rock and then didn't tell anyone for three years. But a new examination reveals it was made by some of the last Neanderthals. When you purchase through links on our site, ...
A decade into reformulating Pfizer’s oral renal cell carcinoma drug Inlyta (axitinib) into a treatment that can be injected for a variety of common eye diseases, Clearside Biomedical is making ...